HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jay W Fox Selected Research

atrolysin A

10/2005Function of the cysteine-rich domain of the haemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jay W Fox Research Topics

Disease

17Hemorrhage
10/2020 - 05/2002
11Neoplasms (Cancer)
01/2020 - 10/2005
8Snake Bites (Snake Bite)
01/2019 - 10/2003
7Wounds and Injuries (Trauma)
11/2021 - 11/2009
6Melanoma (Melanoma, Malignant)
01/2020 - 10/2005
4Neoplasm Metastasis (Metastasis)
01/2012 - 02/2007
3Inflammation (Inflammations)
10/2020 - 06/2005
3Poisoning
01/2019 - 03/2003
3Edema (Dropsy)
11/2009 - 10/2003
3Necrosis
11/2009 - 06/2005
3Glomerulonephritis
11/2006 - 05/2002
2Blister (Bulla)
11/2021 - 01/2019
2Disease Progression
01/2012 - 09/2010
2Proteinuria
11/2006 - 09/2005
1Lymphocytosis
01/2022
1Shock
10/2020
1Alzheimer Disease (Alzheimer's Disease)
01/2019
1Lymphatic Metastasis
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2017
1Carcinoma (Carcinomatosis)
12/2015
1Carcinogenesis
01/2015
1Breast Neoplasms (Breast Cancer)
11/2014
1Ductal Carcinoma
11/2014
1Type 2 Diabetes Mellitus (MODY)
07/2013
1Fibrosis (Cirrhosis)
06/2013
1Leg Ulcer
09/2010
1Hypertension (High Blood Pressure)
07/2009
1Autolysis
06/2009
1Osteosarcoma (Osteogenic Sarcoma)
10/2005
1Hypotension (Low Blood Pressure)
06/2005

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2003
14VenomsIBA
11/2021 - 10/2003
14Metalloproteases (Metalloproteinases)IBA
01/2020 - 10/2003
14Snake Venoms (Snake Venom)IBA
04/2016 - 03/2003
5Peptides (Polypeptides)IBA
01/2018 - 05/2002
4Extracellular Matrix ProteinsIBA
01/2020 - 12/2006
4Collagen Type IV (Type IV Collagen)IBA
04/2016 - 09/2005
3ProteomeIBA
01/2019 - 09/2010
3Biomarkers (Surrogate Marker)IBA
12/2015 - 09/2010
3EnzymesIBA
04/2015 - 10/2003
3Cysteine (L-Cysteine)FDA Link
06/2009 - 10/2005
3EpitopesIBA
11/2006 - 05/2002
2IntegrinsIBA
01/2022 - 01/2015
2Antivenins (Antivenoms)IBA
11/2021 - 01/2012
2Collagen Type I (Type I Collagen)IBA
01/2020 - 10/2005
2Peptide Hydrolases (Proteases)FDA Link
01/2020 - 01/2007
2DisintegrinsIBA
01/2015 - 06/2009
2GelsIBA
01/2012 - 10/2005
2Immunoglobulin G (IgG)IBA
01/2012 - 11/2006
2Interleukin-6 (Interleukin 6)IBA
10/2009 - 09/2005
2Interleukin-8 (Interleukin 8)IBA
10/2009 - 09/2005
2AntibodiesIBA
11/2006 - 05/2002
2CollagenIBA
11/2006 - 10/2005
2AntigensIBA
09/2005 - 05/2002
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2021
1Immunologic Factors (Immunomodulators)IBA
11/2021
1Secretory Phospholipases A2IBA
01/2019
1perlecanIBA
04/2016
1Collagen Type VIIBA
04/2015
1Laminin (Merosin)IBA
04/2015
1nidogen (entactin)IBA
04/2015
1Glucagon-Like Peptide-1 ReceptorIBA
07/2013
1Exenatide (Byetta)FDA Link
07/2013
1Type I Tumor Necrosis Factor ReceptorsIBA
10/2012
1Tissue Inhibitor of Metalloproteinase-1IBA
10/2012
1polyacrylamide gelsIBA
01/2012
1Collagen Type XVIIIBA
08/2010
1Matrix Metalloproteinases (MMPs)IBA
11/2009
1Phospholipases (Phospholipase)IBA
11/2009
1ApolipoproteinsIBA
11/2009
1Apolipoproteins AIBA
11/2009
1Phospholipases A2 (Phospholipase A2)IBA
11/2009
1Non-Fibrillar CollagensIBA
11/2009
1Fibronectins (Fibronectin)IBA
11/2009
1Fibrillar CollagensIBA
11/2009
1Small Interfering RNA (siRNA)IBA
10/2009
1Chemotactic FactorsIBA
10/2009
1CytokinesIBA
10/2009
1ChemokinesIBA
10/2009
1Antihypertensive Agents (Antihypertensives)IBA
07/2009
1Endothelin-1 (Endothelin 1)IBA
02/2007
1Crotalid Venoms (Rattlesnake Venom)IBA
01/2007
1Therapeutic UsesIBA
01/2007
1PoisonsIBA
01/2007
1Membrane Proteins (Integral Membrane Proteins)IBA
09/2006
1atrolysin CIBA
09/2006
1Messenger RNA (mRNA)IBA
10/2005
1Polysaccharides (Glycans)IBA
10/2005
1AlginatesIBA
10/2005
1RNA (Ribonucleic Acid)IBA
10/2005
1Integrin alpha2beta1IBA
10/2005
1atrolysin AIBA
10/2005
1von Willebrand FactorIBA
10/2005
1Bothrops jararaca VenomIBA
09/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2005
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
09/2005
1Interleukin-1beta (Interleukin 1 beta)IBA
09/2005

Therapy/Procedure

3Therapeutics
01/2015 - 07/2009
2Lasers (Laser)
11/2014 - 09/2005
1Intradermal Injections
11/2009